South Africa at a glance
- Population
- 64.7 million 2025
- Life expectancy at birth
- 66.3 years, 2024
- People aged 65 and over
- 6.9 % of people, 2025
- Health spending per person
- 537 US$ per person, 2023
- Doctors
- 0.79 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
South Africa Tissue Engineering Market Industry Trends and Forecast to 2034: Segmented by (Product, Material, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$85.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $37.5 Mn | — | — |
| 2025 (base) | $42.4 Mn | +$4.9 Mn | — |
| 2026 (forecast) | $47.9 Mn | +$5.5 Mn | +13% |
| 2027 (forecast) | $54.1 Mn | +$6.2 Mn | +27.7% |
| 2028 (forecast) | $61.2 Mn | +$7.0 Mn | +44.3% |
| 2029 (forecast) | $69.1 Mn | +$8.0 Mn | +63% |
| 2030 (forecast) | $78.1 Mn | +$9.0 Mn | +84.2% |
| 2031 (forecast) | $88.3 Mn | +$10.2 Mn | +108.2% |
| 2032 (forecast) | $99.7 Mn | +$11.5 Mn | +135.3% |
| 2033 (forecast) | $112.7 Mn | +$13.0 Mn | +165.8% |
| 2034 (forecast) | $127.4 Mn | +$14.7 Mn | +200.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $42.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $127.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 13.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, material and end user (see all) |
| Key players | Organogenesis, Vericel, Integra Life Sciences Corporation, MiMedx, Smith & Nephew (see all) |
| Regulator in South Africa | SAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Tissue engineering builds living tissue such as skin, cartilage and blood vessels from cells and scaffolds to repair the body.
Key segments of the tissue Engineering market include product (Skin Substitutes, Cartilage and Bone Grafts) and material (Synthetic Scaffolds, Biological Scaffolds and Hydrogels).
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the tissue Engineering market.
Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the tissue Engineering market.
Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the tissue Engineering market. Payers are still working out how to pay for one-time cures.
The tissue Engineering market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The South African Health Products Regulatory Authority (SAHPRA) regulates medical devices, starting with licences for the companies that make, import and sell them.[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.[2]
[1] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[2] National Department of Health. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tissue Engineering products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in South Africa.
What doctors and scientists are doing in Tissue Engineering right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
South Africa · 1 shared keyword
South Africa · 1 shared keyword
South Africa · 1 shared keyword
South Africa
South Africa
South Africa
Digital Health · South Africa
Pharmaceuticals · South Africa
Pharmaceuticals · South Africa
Pharmaceuticals · South Africa
Healthcare Services · South Africa
OTC & Nutraceuticals · South Africa